Globe Newswire LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...\n more…
TipRanks Financial Blog OKYO Pharma Limited Sponsored ADR (OKYO) has released an update. OKYO Pharma Limited announced the purchase of 80,000 ordinary shares by Panetta Partners Limited, a...\n more…
Globe Newswire LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...\n more…
Ticker Report OKYO Pharma (NASDAQ:OKYO - Get Free Report) and Moderna (NASDAQ:MRNA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the...\n more…